SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Alto Neuroscience, Inc. (NYSE: ANRO)

Core Points - A shareholder has filed a securities class action lawsuit against Alto Neuroscience, Inc. on behalf of investors who purchased or acquired the company's common stock during its IPO on February 2, 2024, and between February 2, 2024, and October 22, 2024 [1][2] Summary by Sections Lawsuit Details - The lawsuit alleges that the defendants made misrepresentations regarding the clinical, regulatory, and commercial prospects of ALTO-100, a drug aimed at treating major depressive disorder [2] Lead Plaintiff Information - Interested parties wishing to serve as lead plaintiff must file necessary documents by September 19, 2025, and participation as a lead plaintiff is not required to share in any potential recovery [3] Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented both individual investors and large public and private pension funds [4]